Bio-Conference Calender

REGISTER BY OCTOBER 28 AND-SAVE-UP TO-$350 Cambridge Healthtech Institute's Ninth Annual High-Content Analysis January 10-13, 2012 | The Fairmont Hotel | San Francisco, California The most COMPREHENSIVE COVERAGE of HCA applications and technologies. To register click here

...

https://chidb.com/register/2012/hca/reg.asp or go to: https://chidb.com/register/2012/hca/reg.asp Download final agenda http://www.healthtech.com/click-thru/108723/?email=jayantimishra02@gmail.com> Coverage Includes: - HCA for Toxicity Assessment and Drug Screening - High-Content Image Analysis and Data Management - HCA for Pathway Analysis and RNAi - HCA of Stem Cells, Tissues, and Whole Organisms - 3-D Cell Models - Neuronal Imaging - High-Content Flow Cytometry - Novel Probes and Biosensors - High-Content Screening of Live Cells - FLIM-FRET - Miniaturization Approaches - Advanced High-Content Analysis Course http://www.highcontentanalysis.com/hca_content.aspx?id=100918 - January 9, 2012 - User Group Meetings http://www.highcontentanalysis.com/hca_content.aspx?id=107340 - January 10 and 12, 2012 - Co-Located Live-Cell Imaging Meeting http://www.healthtech.com/Live-Cell-Imaging/ - January 12-13, 2012 Distinguished Faculty Includes: Dominic Alibhai, Paul French's Lab, Photonics, Imperial College London Steven Altschuler, Ph.D., Associate Professor, Pharmacology and Green Center for Systems Biology, University of Texas, Dallas David Andrews, Ph.D., Professor, Biochemistry and Biomedical Sciences, McMaster University Peter Antinozzi, Ph.D., Assistant Professor, Biochemistry,Wake Forest University School of Medicine Joe Chalfoun, Ph.D., Research Scientist, Bio-Robotics, ITL,National Institute of Standards and Technology Normand J. Cloutier, Ph.D., Support Manager for Scientific Applications, Research Informatics Services, *Bristol-Myers Squibb Davide Danovi, M.D., Ph.D., Research Associate, Samantha Dickson Brain Cancer Unit, UCL Cancer Institute, University College London Anthony M. Davies, Ph.D., Director, *Irish National Center for High-Content Screening and Analysis (INCHA) Michelle A. Digman, Ph.D., Research Associate, University of California, Irvine; Director, W.M. Keck Nanoimaging Lab, Laboratory for Fluorescence Dynamics (LFD) Hakim Djaballah, Ph.D., Director, HTS Core Facility, Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center David Drubin, Ph.D., Professor, Molecular and Cell Biology, University of California, Berkeley Scott Eastman, Ph.D., Senior Research Scientist, Cell Biology and BioImaging, ImClone Systems, Inc. Dan Ehrlich, Ph.D., Research Professor, Biomedical Engineering,Boston University Paul French, Ph.D., Professor, Physics; Head, Photonics Group, Imperial College London N. Gautam, Ph.D., Professor, Anesthesiology and Genetics, Washington University School of Medicine Bonnie Goodwin, Ph.D., MPH, Biologist, NIH Center for Translational Therapeutics, NHGRI, NIH Marjo Götte, Ph.D., Research Investigator III, Lead Finding platform, Novartis Institutes for Biomedical Research Rebecca Green, Ph.D., Postdoctoral Fellow, Laboratory of Mitotic Mechanisms, Ludwig Institute for Cancer Research, University of California, San Diego Rajarshi Guha, Ph.D., Informatics Scientist,NIH Center for Translational Therapeutics Shelley Halpain, Ph.D., Professor, Division of Biological Sciences, University of California, San Diego Michael Henkel, Ph.D., Scientist, Lead Discovery, Amgen Research GmbH Susanne Heynen-Genel, Ph.D., Director, High-Content Screening Systems,Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute Elizabeth Hong-Geller, Ph.D., Staff Scientist, Bioscience Division, Los Alamos National Laboratory Peter Horvath, Ph.D., Head, Data Analysis Group, Light Microscopy Center, ETH Zurich James D. Johnson, Ph.D., Associate Professor, Department of Cellular and Physiological Sciences, Department of Surgery, University of British Columbia Paul A. Johnston, Ph.D., Research Associate Professor, Department of Pharmaceutical Sciences, School of Pharmacy, Drug Discovery Institute, University of Pittsburgh School of Medicine Karol Kozak, Ph.D., Head, Data Handling Unit and High-Content Screening, ETH Zurich Eberhard Krausz, Ph.D., Director, Assay Development & Target Validation, Janssen Research & Development Peter Krutzik, Ph.D., Senior Scientist, Baxter Lab in Genetics Pharmacology, Microbiology and Immunology, Stanford University Vance Lemmon, Ph.D., Professor, Basic Science Research Labs, Miller School of Medicine, *University of Miami and many more... Exhibit and Sponsorship Information Sponsors and Exhibitors will enjoy facilitated networking opportunities with 400 international scientists and executives. Enhance business development and lead generation initiatives by presenting and exhibiting your expertise to this qualified, hard-to-reach market. Prospectus: http://www.highcontentanalysis.com/hca_content.aspx?ekfrm=100559 For more information contact: Katelin Fitzgerald, Manager, Business Development T: 781-972-5458 E: kfitzgerald@healthtech.com For more information about the program, please contact: Julia Boguslavsky, Executive Director, Conferences E-mail: juliab@healthtech.com http://www.highcontentanalysis.com/ http://www.highcontentanalysis.com/